1. High-risk RA patients have a 20% ILD development rate in 15 years.
2. Study involved 2,507 patients from the VA RA registry.
3. Composite biomarker score was created from 8 proteins.
4. ILD prediction improved with added clinical factors.
5. Matrix metalloproteinase-7's role was significant.
6. Generalizability of findings is uncertain due to the sample population.
7. Blood biomarkers may enable early monitoring and intervention.

Source: Arthritis and Rheumatology